AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 7923517
Drug: Vecuronium administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium administered to patients with HPT
Trial: 7923517
Drug: Vecuronium administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium administered to control patients
Trial: 31830868
Drug: arts therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: arts therapies intervention
Trial: 22920307
Drug: Dual antiplatelet
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual antiplatelet therapy (75 mg of clopidogrel in addition to 300 mg of aspirin)
Trial: 22920307
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (300 mg of aspirin)
Trial: 19702702
Drug: Topical cyclosporine
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical cyclosporine A (CsA) 0.05% ophthalmic emulsion twice daily and concomitant five times daily non-preserved artificial tear
Trial: 19702702
Drug: Vehicle emulsion
RxNorm normalized name: propofol lipid emulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vehicle emulsion twice daily and non-preserved artificial tear five times daily (Control)
Trial: 17688611
Drug: ISMN‐SR 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ISMN‐SR 60 mg vaginally
Trial: 17688611
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C 100 mg vaginally
Trial: 7869468
Drug: Methadone plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methadone plus 3 mg guanfacine
Trial: 7869468
Drug: Methadone plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methadone plus 4 mg guanfacine
Trial: 3122549
Drug: Active nitroglycerin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active nitroglycerin patch
Trial: 27718280
Drug: Cervical pessary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cervical pessary plus 400 mg daily vaginal progesterone (group B)
Trial: 27718280
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg daily vaginal progesterone (group A)
Trial: 24933496
Drug: Brief telephone-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brief telephone-based cognitive-behavioral therapy intervention
Trial: 22513062
Drug: Lidocaine 2%
RxNorm normalized name: LIDOCAINE 2% GEL,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine 2% plus adrenaline 1:200,000 (group L)
Trial: 15882226
Drug: Regular treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular treatment based on instruction of proper prophylactic dental care
Trial: 12563046
Drug: Selective head
RxNorm normalized name: Head & Shoulders
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective head cooling with rectal temperature maintained at 35.0 degrees C
Trial: 12563046
Drug: Selective head
RxNorm normalized name: Head & Shoulders
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective head cooling with rectal temperature maintained at 34.5 degrees C
Trial: 10668583
Drug: Cefepime (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefepime (1 g b.i.d.)
Trial: 10668583
Drug: Ceftazidime (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftazidime (1 g t.i.d.)
Trial: 8250520
Drug: Pentasa (mesalazine)
RxNorm normalized name: mesalamine Enema [Pentasa]
DrugBank: Mesalazine (DB00244)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pentasa (mesalazine) 2 g/day
Trial: 3472450
Drug: Oral salt
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral salt loading (normal diet + 200 mmol NaCl/day for 4 weeks followed by normal diet + 400 mmol/day for 1 week)
Trial: 29380951
Drug: Low sex
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low sex hormone condition (gonadotropin releasing hormone antagonist, aromatase inhibitor, and placebo gel)
Trial: 29380951
Drug: Testosterone add‐back
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone add‐back condition (testosterone gel)
Trial: 22566311
Drug: 15 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 g/d I-PHGG (fiber group)
Trial: 17950101
Drug: Intravenous glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous glucose with amino acids
Trial: 17950101
Drug: Intravenous glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous glucose without amino acids (control)
Trial: 15677624
Drug: Chemotherapy following
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chemotherapy following resection
Trial: 12121731
Drug: Botulinum A
RxNorm normalized name: Botulinum antitoxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum A toxin (100 IU in 4 ml of 9% saline)
Trial: 12121731
Drug: Lidocaine (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine (4 ml of 0.5%)
Trial: 7662601
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg isosorbide dinitrate (first dose)
Trial: 7662601
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg isosorbide dinitrate (second dose)
Trial: 2811943
Drug: Systemic prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Systemic prednisone (0.4 to 0.5 mg/kg for one month, gradually withdrawn over three months)
Trial: 2811943
Drug: Radioiodine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radioiodine treatment alone
Trial: 30286300
Drug: Sprint Interval
RxNorm normalized name: norgestimate
DrugBank: Norgestimate (DB00957)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sprint Interval Training (SIT) executed twice a week
Trial: 28619114
Drug: smartphone-based monitoring
FDA approved: no
EMA approved: no
PMDA approved: no
Description: smartphone-based monitoring system including an integrated feedback loop and context-aware cognitive behavioral therapy (CBT) modules
Trial: 21211064
Drug: Weekly reminder
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly reminder and motivational text messages
Trial: 12939852
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of treatment, infarct location, and enzyme level
Trial: 22369270
Drug: Hydroxychloroquine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxychloroquine treatment
Trial: 12451430
Drug: Fluconazole 200
RxNorm normalized name: fluconazole 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluconazole 200 mg once daily for 11 days
Trial: 1752602
Drug: Bromocriptine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromocriptine (10 patients randomized to receive this treatment)
Trial: 7234826
Drug: Tolmetin (2,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolmetin (2,000 mg/day)
Trial: 28509517
Drug: Test group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test group (oral health promotion package including pamphlet, baby toothbrush, fluoride toothpaste 1,000 mg/L, trainer cup)
Trial: 24816536
Drug: Lidocaine 1%
RxNorm normalized name: LIDOCAINE 1% LOTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine 1% (0.5 mg/kg)
Trial: 24816536
Drug: Remifentanil (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil (1 µg/kg)
Trial: 24816536
Drug: Fentanyl (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl (1 µg/kg)
Trial: 22772951
Drug: High pretreatment
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High pretreatment NLR that declined after treatment
Trial: 15497667
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation (clopidogrel bisulfate, 75 mg)
Trial: 9443770
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg bisoprolol daily for 8 weeks
Trial: 9443770
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg captopril twice daily for 8 weeks
Trial: 7946439
Drug: Fludarabine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fludarabine treatment
Trial: 27520090
Drug: Blood loss
RxNorm normalized name: dragon's blood extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood loss (BL) of 1000 ml
Trial: 22739998
Drug: No epidural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No epidural steroid injection (No-ESI)
Trial: 20877623
Drug: rAd5 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rAd5 vaccine alone (1×10^10 or 1×10^11 particle units)
Trial: 20877623
Drug: rAd5 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rAd5 vaccine alone
Trial: 20877623
Drug: rAd5 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rAd5 vaccine alone or DNA prime - rAd5 boost
Trial: 19035857
Drug: Annual screening
RxNorm normalized name: annual bluegrass pollen extract
DrugBank: Poa annua pollen (DB10353)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Annual screening with PSA (abnormal >4.0 ng/mL) and DRE
Trial: 14510719
Drug: Inhaled beclomethasone
RxNorm normalized name: beclomethasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled beclomethasone dipropionate (400 microg bid)
Trial: 14510719
Drug: Inhaled beclomethasone
RxNorm normalized name: beclomethasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled beclomethasone dipropionate (200 microg bid)
Trial: 6220672
Drug: Norfloxacin 200
RxNorm normalized name: Norfloxacin
DrugBank: Norfloxacin (DB01059)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Norfloxacin 200 mg
Trial: 6220672
Drug: Norfloxacin 800
RxNorm normalized name: Norfloxacin
DrugBank: Norfloxacin (DB01059)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Norfloxacin 800 mg
Trial: 6220672
Drug: Norfloxacin 1200
RxNorm normalized name: Norfloxacin
DrugBank: Norfloxacin (DB01059)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Norfloxacin 1200 mg
Trial: 6220672
Drug: Norfloxacin 1600
RxNorm normalized name: Norfloxacin
DrugBank: Norfloxacin (DB01059)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Norfloxacin 1600 mg
Trial: 30072173
Drug: Music Group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music Group (daily listening to experiential/traditional music)
Trial: 30072173
Drug: Control Group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control Group (standard care only, no music therapy)
Trial: 26911380
Drug: Quetiapine XR
RxNorm normalized name: quetiapine Extended Release Oral Tablet
DrugBank: Quetiapine (DB01224)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Quetiapine XR (300 mg/day)
Trial: 12560588
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (non-drug)
Trial: 10138581
Drug: Intervention phase
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intervention phase with dosage interval adjustment recommendations by staff pharmacists
Trial: 10138581
Drug: Baseline phase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline phase without dosage interval adjustment
Trial: 998534
Drug: Saturated diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saturated diet with added cholesterol (291 mg)
Trial: 998534
Drug: Polyunsaturated diet
RxNorm normalized name: OMEGA-3 POLYUNSATURATES
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polyunsaturated diet with added cholesterol (291 mg)
Trial: 27681865
Drug: Concurrent chemoradiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent chemoradiation (cCRTX)
Trial: 10994885
Drug: Thyrotropin-releasing hormone
RxNorm normalized name: thyrotropin-releasing hormone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thyrotropin-releasing hormone (TRH) at a dose of 0.1 mg/kg for 29 days
Trial: 8851268
Drug: Taprostene administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Taprostene administered as a continuous intravenous infusion from 2 hours before until 8 or 24 hours after angioplasty.
Trial: 8851268
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group received a combination of 330 mg aspirin and 75 mg dipyridamole.
Trial: 8851268
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (aspirin and dipyridamole).
Trial: 10147024
Drug: Aminoglycoside/antianaerobe combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aminoglycoside/antianaerobe combination regimens
Trial: 6337200
Drug: Aspirin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (10 gr twice daily)
Trial: 29651981
Drug: Lamotrigine (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lamotrigine (up to 200 mg/day, or up to 400 mg/day for women on combined oral contraceptives)
Trial: 24739593
Drug: Clopidogrel and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel and aspirin (combination therapy)
Trial: 19837920
Drug: ID fat
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ID fat infusion with orlistat
Trial: 16270634
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human FXIII A2 (rFXIII) at doses of 10 or 25 U/kg
Trial: 11801583
Drug: Liposomal amphotericin
RxNorm normalized name: Liposomal amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Liposomal amphotericin B (AmBisome) 4 mg/kg/day
Trial: 7754475
Drug: Minocycline (Mynocine)
RxNorm normalized name: minocycline Injection [Minocin]
DrugBank: Minocycline (DB01017)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Minocycline (Mynocine) 100 mg per day
Trial: 7754475
Drug: Roxithromycin (Rulid)
RxNorm normalized name: roxithromycin
DrugBank: Roxithromycin (DB00778)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Roxithromycin (Rulid) 300 mg per day
Trial: 2407004
Drug: 15-deoxyspergualin (DSG)
RxNorm normalized name: Deoxyspergualin
DrugBank: Deoxyspergualin (DB12991)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15-deoxyspergualin (DSG) at various dosages (40 mg/m2, 80 mg/m2, 120 mg/m2, 180 mg/m2, 220 mg/m2)
Trial: 2407004
Drug: Combined use
RxNorm normalized name: CORTICOSTEROIDS FOR SYSTEMIC USE, COMBINATIONS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined use of 15-deoxyspergualin (DSG) with other agents
Trial: 30655198
Drug: Succinylcholine (group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Succinylcholine (group SUX) for intubation with no further NMB administered
Trial: 26717354
Drug: Sargassum extract
RxNorm normalized name: Sargassum pallidum extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sargassum extract 250 μg/mL
Trial: 26717354
Drug: Sargassum extract
RxNorm normalized name: Sargassum pallidum extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sargassum extract 500 μg/mL
Trial: 19639620
Drug: 1,550 nm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,550 nm Er:Glass fractional laser (3 treatments with 6-week intervals)
Trial: 19639620
Drug: CROSS method
RxNorm normalized name: Red Cross Canker Sore
DrugBank: Benzocaine (DB01086)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CROSS method (2 treatments every 12 weeks)
Trial: 10543411
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg glimepiride
Trial: 11903417
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg glimepiride
Trial: 8432776
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose alpha human atrial natriuretic peptide (ANP) infusion (2.5 pmol/kg.min)
Trial: 27426932
Drug: 7.44 mg
RxNorm normalized name: aluminum sulfate 7.44 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.44 mg total macular carotenoid
Trial: 27426932
Drug: 13.13 mg
RxNorm normalized name: DIMETHICONE 13.13 mg in 1 mL TOPICAL LOTION [Daily Moisturizing]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 13.13 mg total macular carotenoid
Trial: 27426932
Drug: 27.03 mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 27.03 mg total macular carotenoid
Trial: 16622454
Drug: Docetaxel 80
RxNorm normalized name: DOCETAXEL 80MG/VIL INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Docetaxel 80 mg m‐2 and epirubicin 75 mg m‐2 (ED)
Trial: 16622454
Drug: Docetaxel 100
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel 100 mg m‐2 (D)
Trial: 11763004
Drug: Olanzapine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine (10 mg daily for 6 weeks)
Trial: 8989002
Drug: Propofol (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (0.1 mg/kg bolus followed by 1 mg.kg-1.h-1 continuous infusion)
Trial: 31538405
Drug: Transforaminal epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transforaminal epidural injection of 1 mL 0.5% bupivacaine with 3 cycles of pulsed radiofrequency of the DRG for 180 seconds (LPRF group)
Trial: 31538405
Drug: Transforaminal epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transforaminal epidural injection of 1 mL 0.5% bupivacaine (LA group)
Trial: 29309313
Drug: Automated mechanical
RxNorm normalized name: PIPERONYL BUTOXIDE TECHNICAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Automated mechanical peripheral stimulation (AMPS) applied twice a week for 4 weeks using a commercial medical device (Gondola) delivering mechanical pressure in four areas of feet.
Trial: 29309313
Drug: AMPS SHAM
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMPS SHAM (placebo) applied twice a week for 4 weeks delivering subliminal stimulus.
Trial: 26343552
Drug: Scaling and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scaling and root planing (SRP) with adjunctive use of an essential-oil (EO)-based oral rinse for 30 days
Trial: 9369828
Drug: Single-dose cefotetan
RxNorm normalized name: Cefotetan
DrugBank: Cefotetan (DB01330)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single-dose cefotetan (2 gm intravenous)
Trial: 9369828
Drug: Multiple-dose cefotetan
RxNorm normalized name: Cefotetan
DrugBank: Cefotetan (DB01330)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multiple-dose cefotetan (2 gm intravenous every 12 hours for a minimum of 48 hours)
Trial: 9369828
Drug: Single-dose cefotetan
RxNorm normalized name: Cefotetan
DrugBank: Cefotetan (DB01330)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single-dose cefotetan
Trial: 9369828
Drug: Multiple-dose cefotetan
RxNorm normalized name: Cefotetan
DrugBank: Cefotetan (DB01330)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multiple-dose cefotetan
Trial: 30962409
Drug: HL301 (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HL301 (600 mg/day)
Trial: 31855086
Drug: Umckamin (333
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Umckamin (333 mg/day)
Trial: 31720257
Drug: Resistant starch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resistant starch (13.5 g Hi-Maize 260 daily for 4 weeks)
Trial: 21411598
Drug: Control (EPI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (EPI vaccines alone)
Trial: 15988081
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment with Depakin (30 mg/kg) and Mexidol (5 mg/kg) in children with generalized epilepsy.
Trial: 15988081
Drug: Monotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotherapy with Mexidol (5 mg/kg) in children with first episode of febrile seizures.
Trial: 15988081
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group without any treatment in children with first episode of febrile seizures.
Trial: 10491894
Drug: Intravenous dipyridamole
RxNorm normalized name: Dipyridamole
DrugBank: Dipyridamole (DB00975)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous dipyridamole 10 mg every 8 hours
Trial: 10491894
Drug: Oral aspirin
RxNorm normalized name: aspirin Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral aspirin 300 mg every 24 hours
Trial: 8708728
Drug: Liposomal daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liposomal daunorubicin (DaunoXome) 40 mg/m2
Trial: 6753911
Drug: Captopril 37.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 37.5 mg, 75 mg or 150 mg/day for 7 weeks
Trial: 6753911
Drug: Captopril plus
RxNorm normalized name: Captopril
DrugBank: Captopril (DB01197)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Captopril plus hydrochlorothiazide 25 mg twice daily